WELCOME TO BRANFORD: THE WORLD’S ONLY HIV-DEDICATED RESEARCH FACILITY
What makes Branford different?
Mark Cockett, our Head of Discovery, explains exactly why Branford is so unique:
Hear from Mark Cockett as he discusses the work at the Branford facility
Leaving no patient behind
The patient is at the forefront of everything we do. “ViiV is very much focused on patients, focused on every aspect of a patient's life and how we might improve that with the drugs and products that we produce,” says Mark Cockett.
No two patients are the same. While one might be very happy on the drugs they are on, another may struggle to take their medication regularly, or develop a form of resistance, or even suffer side effects. Developing drugs that solve these issues for the patient is what drives the Branford facility, and every day we get a little closer.
“We've got several things in the pipeline that we're working on. It just means eventually we'll have more options for patients who are living with HIV, which is really what brings me to work every day,” says Michelle DeGrosky, Clinical Development, ViiV Healthcare.
- Pei-Ying W, Mao-Yuan C, Szu-Min H, et al. Comorbidities among the HIV-Infected Patients Aged 40Years or Older in Taiwan. PLOS One. 2014;9(8):18.